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Rsp5p Is Required for ER Bound Mga2p120
Polyubiquitination and Release of the
Processed/Tethered Transactivator Mga2p90
molecular-weight 120 kDa proteins by a limited endo-
proteolytic proteasome degradation mechanism [2]. As
mentioned in the Summary, Rsp5p’s essential function
within the OLE1 transactivation pathway has been attrib-
uted to providing the partial degradation signal for both
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3 Department of Biochemistry [2]. Placing the tag at the amino-terminus of Mga2p
Drexel University School of Medicine allows for the detection of unprocessed and processed
Philadelphia, Pennsylvania 19102 proteins with an anti-MYC antibody [2]. MYCMGA2 cells
were then transformed with plasmid bearing a galac-
tose-inducible HArsp5c. spt23 cells transformed with
Summary plasmids harboring FLAGSPT23 and HArsp5c were in-
cluded as a control. Surprisingly, HARsp5pC inhibited
A number of eukaryotic transcription factors are held Spt23p but not Mga2p processing (Figure 1A). The in-
in a latent state by being embedded in, or tethered to, ability to detect a defect in Mga2p processing in cells
cellular membranes. Mga2p of Saccharomyces cere- expressing HARsp5pC is unlikely to be due to absence
visiae is an endoplasmic reticulum (ER)-localized tran- of activity (i.e., inhibiting endogenous Rsp5p function)
scription factor that plays an overlapping role with because HARsp5pC suppresses MYCMga2p-induced
homologous Spt23p in upregulating expression of OLE1 expression and MYCMGA2 cells expressing the mu-
OLE1, a gene required for the synthesis of essential tant require oleic acid for growth (see Figure S1 in the
oleic acid [1]. Previous studies have documented that Supplemental Data available with this article online). To
proteasome-dependent processing of ER bound 120
determine if Rsp5p is dispensable for Mga2p processing
kDa Mga2p and Spt23p proteins generates transcrip-
by alternative methods, we tested if Mga2p90 is pro-
tionally competent 90 kDa polypeptides [2]. In the case
duced in rsp5-1 cells at the nonpermissive temperatureof Spt23p90, it is held at the membrane prior to release
and in rsp5 cells. The MGA2 and SPT23 plasmids usedvia a self-interaction with the unprocessed Spt23p120
for these experiments harbor tags on both the aminoanchor [3]. It is currently thought that the highly con-
and carboxy-terminal ends of the encoded proteins (seeserved Rsp5p ubiquitin ligase provides the signal for
picture in Figure 1E). This allows for the detection ofpartial degradation of both proteins. Cells lacking
unprocessed (membrane bound) and processed (teth-Rsp5p function require oleic acid for growth, and
ered) polypeptides with an anti-FLAG antibody or theSpt23p processing is suppressed in rsp5 cells and
detection of only unprocessed proteins with the anti-in wild-type RSP5 cells upon expression of Rsp5p
HA antibody [2]. As shown in Figure 1B, there was nodominant-negative mutants [2, 4]. We report here that
obvious difference in Mga2p90 levels in rsp5-1 cellsRsp5p is dispensable for Mga2p90 generation but not
versus wild-type cells at the nonpermissive temperaturefor release of the processed product from the ER.
(i.e., 37C), whereas less Spt23p90 was observed inIn addition, we demonstrate that polyubiquitinated
rsp5-1 cells at 37C (Figure 1B). Also, FLAGMga2p90 wasMga2p120 accumulates in cells lacking Npl4p or pro-
produced in rsp5 cells, and this protein contained theteasome function and Rsp5p is required for Mga2p120
amino-terminal region and lacked carboxy-terminalpolyubiquitination. Finally, we provide evidence that
amino acids (as determined by positive anti-FLAG andMga2p90 and Mga2p120 dimerize and that Rsp5p
negative anti-HA reactivity; Figure 1C). Consistent withbinds heterodimeric Mga2p complexes both in vitro
previous studies [2], Spt23p90 expression was dramati-and in vivo. In light of these experiments, we propose
cally lower, if not detectable, in rsp5 cells. We concludethat Rsp5p facilitates Mga2p90 release from the ER by
from these studies that Rsp5p activates Mga2p’s OLE1promoting polyubiquitination and Npl4p-proteasome-
transactivation function by a mechanism that is indepen-mediated degradation of the interacting Mga2p120 ER
dent of promoting proteasome-dependent processing.bound anchor.
We next examined if Rsp5p functions up- or down-
stream of Mga2p90 release from the ER. Indirect immu-Results
nofluorescence was performed with MYCMGA2 cells con-
taining an empty vector control (V) or expressing theRsp5p Is Dispensable for Processing
Rsp5p dominant-negative mutant. As shown in Figurebut Not ER Release of Mga2p
Prior studies suggest that transcriptionally active 1D, MYCMga2p exhibited ER, perinuclear, and nuclear
Spt23p90 and Mga2p90 are generated from larger- staining in mock-induced cells, and this result is consis-
tent with previous studies [5]. In contrast, predominant
ER staining of MYCMga2p was evident in cells expressing*Correspondence: dhaines@temple.edu
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Figure 1. Rsp5p Is Dispensable for Processing but Not ER Release of Mga2p
(A) Yeast harboring the indicated plasmids were grown in glucose media and incubated in galactose media to induce expression of HArsp5c.
Cells were harvested, and Western blotting was carried out with the appropriate antibodies.
(B) Wild-type and rsp5-1 cells were transformed with galactose-inducible FLAGMGA2HA or FLAGSPT23HA. Transformants were grown in glucose
media, pelleted, and resuspended in galactose media. Cells were placed at 37C. Cells were harvested, and the amount of epitope-tagged
protein was determined by a Western blot with an anti-FLAG antibody.
(C) rsp5 and wild-type cells containing galactose-inducible FLAGMGA2HA or FLAGSPT23HA were grown in glucose media containing oleic acid.
Cells were pelleted and resuspended in galactose media supplemented with oleic acid. Cells were harvested, and Western blotting was
performed with the indicated antibodies.
Activation of Mga2p by Rsp5p
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Figure 2. Polyubiquitinated Mga2p120 Ac-
cumulates in Cells Lacking Npl4p or Protea-
some Function, and Rsp5p Is Required for
Mga2p120 Polyubiquitination
(A) npl4-1 and wild-type cells containing
MYCMGA2 were grown in media at 25C and
placed at the nonpermissive temperature of
30C. Cells were harvested, and immunopre-
cipitations were carried out with an anti-Myc
or isotype control (I) antibody. Immunopre-
cipitated proteins were resolved by SDS-
PAGE, and Western blotting was performed
with an anti-Ub antibody.
(B) rpn4 cells expressing FLAGMga2pHA were
incubated for 2 hr in the absence (-) or pres-
ence () of the proteasome inhibitor Z-Leu-
Leu-Leu-B(OH)2. Immunoprecipitation and
Western blotting were performed with the in-
dicated antibodies.
(C) npl4-1 cells harboring MYCMGA2 were
transformed with pYes-HArsp5c or with an
empty vector control (V). Transformants were
grown in glucose media and then incubated
in galactose media. Cells were harvested, im-
munoprecipitations were performed with an
anti-MYC or isotype control (I) antibody, and
blots of immunoprecipitated proteins were
probed with the indicated antibodies.
(D) rsp5 and wild-type cells containing ga-
lactose-inducible FLAGMGA2HA were grown in
glucose media in the presence of oleic acid
and then placed in oleic acid-supplemented
galactose media. Cells were harvested and
immunoprecipitations and Western blotting
were performed with the indicated anti-
bodies.
HARsp5pC. We performed fractionation experiments to dual epitope-tagged Mga2p in rsp5 cells versus wild-
type cells. ER, perinuclear, and nuclear localization wereverify that nuclear mobilization of MYCMga2p90 is sup-
pressed in cells expressing HARsp5pC. Extracts en- detected with the anti-FLAG antibody, whereas ER
staining was seen with the anti-HA antibody in cellsriched for microsomal, ER/nuclei, and nucleoplasm pro-
teins were generated. Western blotting was performed containing wild-type RSP5 (Figure 1F). In contrast, epi-
tope-tagged Mga2p in rsp5 cells was found to be local-with anti-MYC, anti-Dpm1p (Dpm1p is ER-localized),
and anti-Nop1p (Nop1p is nucleoplasm localized) ized predominantly to the ER, regardless of whether the
anti-FLAG or anti-HA antibody was used. These resultsantibodies. In mock-induced cells, unprocessed
MYCMga2p120 was found predominantly in crude and suggest that Rsp5p is required for ER release of
Mga2p90.microsomal preparations, whereas MYCMga2p90 was de-
tected in all fractions analyzed (Figure 1E). In cells ex-
pressing HARsp5pC, MYCMga2p120 and MYCMga2p90 Polyubiquitinated Mga2p120 Accumulates in Cells
Lacking Npl4p or Proteasome Function andwere detected in microsomal and ER/nuclear fractions,
whereas no MYCMga2p90 was measured in the nucleo- Rsp5p Is Required for Mga2p120
Polyubiquitinationplasm. Because there is no detectable MYCMga2p120
or MYCMga2p90 in the nucleoplasm in cells expressing Rsp5p has recently been shown to ubiquitinate ER-
localized proteins [6]. Thus, we next tested if Rsp5p-HARsp5pC, the greater amount of MYCMga2p120 and
MYCMga2p90 in the ER/nuclear extracts prepared from induced mobilization of Mga2p90 is linked to Rsp5p-
dependent ubiquitination of ER bound Mga2p120 orthese cells could be due to HARsp5pC-induced stabili-
zation of ER-localized MYCMga2p120 and MYCMga2p90. tethered Mga2p90. Unfortunately, we have found it diffi-
cult to detect ubiquitinated forms of Mga2p in MYCMGA2To gain further evidence that Rsp5p is required for ER
release of Mga2p90, we compared the localization of cells, which is likely due in part to the insensitive nature
(D) MYCMGA2 cells were transformed with pYes-HArsp5c or an empty vector (V) control. Cells were grown and induced as described above,
and immunofluorescence was performed with an anti-MYC antibody.
(E) Extracts enriched for microsomal, ER/nuclei, and nucleoplasm proteins were generated, and Western blotting was performed with anti-
MYC, anti-Dpm1p, and anti-Nop1p antibodies.
(F) rsp5 and wild-type cells containing galactose-inducible FLAGMGA2HA were grown and induced as described above, and the localization of
epitope-tagged Mga2p was determined by immunfluorescence with the indicated antibodies.
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Figure 3. Mga2p90 and Mga2p120 Form
Heterodimers
(A) mga2 harboring pYes-FLAGMGA2HA were
grown in glucose media and incubated in ga-
lactose media. Cells were pelleted and lysed,
and immunoprecipitations were carried out
with an anti-HA or isotype control (I) antibody.
Immunoprecipitated material was resolved
by SDS-PAGE, and Western blots were per-
formed with the indicated antibodies. An as-
terisk denotes FLAGMag2p90.
(B) His6X-tagged Mga2p was purified from
bacteria using Ni2 agarose beads and incu-
bated with [35S] labeled Mga2p 1-788 or
Mga2p1-788IPT. Protein complexes were
pelleted, washed and eluted by re-sus-
pending beads in SDS-PAGE loading buffer and boiling. Proteins were resolved by SDS-PAGE and dried gels were subjected to fluorography.
V denotes binding reactions containing Ni2 agarose beads that had been incubated with bacteria containing the empty His6X vector. The left
panel depicts recombinant (detected by Coomassie staining) and in vitro translated (detected by fluorography) Mga2p placed in the binding
assay.
of anti-Ubiquitin (Ub) antibodies. This has prevented us FLAGMga2p120HA in cells containing RSP5 but not in rsp5
cells. These results suggest that Rsp5p is required forfrom determining if ectopic expression of HARsp5pC
suppresses MYCMga2p ubiquitination under normal Mga2p120 polyubiquitination. We should point out that
we have not observed convincing differences in the sta-growth conditions. We have found, however, that poly-
ubiquitinated MYCMga2p accumulates to easily measur- bility (as measured by pulse-chase with radioactively
labeled methionine) of MYCMga2p120 in cells deficient inable levels in npl4-1 mutant cells at the nonpermissive
temperature and, curiously, that the majority of ubiquiti- Rsp5p or Npl4p. This result is not surprising; this assay
is insensitive, and loss of Rsp5p or Npl4p function doesnated MYCMga2p possesses a molecular weight greater
than 120 kDa (Figure 2A). Also, we have found that simi- not lead to an obvious increase in total Mga2p120. Fur-
thermore, the inability to detect labeled Mga2p in frac-lar to Spt23p processing [3], MYCMga2p processing is
unaffected, and both Mga2p120 and Mga2p90 are ER tions enriched for ER and nuclear protein in wild-type
cells has prevented us from determining if increasedlocalized in npl4-1 mutant cells at nonpermissive tem-
peratures (see Figure S2 in the Supplemental Data). amounts of Mga2p120 and Mga2p90 detected in this
particular fraction in cells expressing HARsp5pC areNpl4p is an essential member of the Cdc48p-Ufd1p pro-
tein chaperone complex, and it has recently been impli- associated with enhanced stability of these ER-seques-
tered proteins. The simplest interpretation of the datacated in binding polyubiquitinated ER-localized pro-
teins, separating them from nonmodified partners, and is that there is only a minor sub-pool of ER-localized
Mga2p120 that has the capacity to be poly-ubiquitinatedpresenting them to the proteasome for degradation (re-
viewed in [7]). Considering the emerging role of this by Rsp5p and degraded via an Npl4p-proteasome-
dependent mechanism under the conditions used here.complex in the degradation of poly-ubiquitinated ER-
localized proteins, it is likely that ER bound MYCMga2p120
is a substrate of the ubiquitination machinery and that Mga2p90 and Mga2p120 Form Heterodimers,
and the Mga2p90-Mga2p120 ComplexNpl4p is required for proteasome-dependent degrada-
tion of polyubiquitinated Mga2p120 and release of teth- Interacts with Rsp5p
One question that arises from these studies is how doesered Mga2p90. Consistent with the idea that polyubiqui-
tinated Mga2p120 is a substrate of the proteasome, Rsp5-dependent Mga2p120 polyubiquitination lead to
Rsp5p-dependent release of Mga2p90? When one con-these forms were found to accumulate in rpn4 cells
(these cells display an increased sensitivity to protea- siders that homologous Spt23p90 and Spt23p120 het-
erodimerize via the IPT domain [3] and Mga2p harborssome inhibitors [8]) treated with the proteasome inhibitor
Z-Leu-Leu-Leu-B(OH)2 (Figure 2B). the same motif, one plausible explanation is that
Mga2p90 and Mga2p120 interact and that Rsp5p bind-We next determined if Rsp5p is required for Mga2p120
polyubiquitination. We accomplished this by measuring ing to the complex results in Mga2p120 polyubiquitina-
tion and degradation with release of heterodimericthe amount of polyubiquitinated Mga2p120 in npl4-1
mutant cells at the nonpermissive temperature with or Mga2p90. To determine if epitope-tagged Mga2p90 and
Mga2p120 heterodimerize, we performed coimmuno-without expression of HARsp5pC as well as in wild-
type RSP5 versus rsp5 cells. The galactose-inducible precipitation studies with cells expressing FLAGMga2pHA.
Figure 3A shows FLAGMga2p90 in immunoprecipitationsFLAGMGA2HA plasmid was used for the later studies be-
cause it allows for a high level of Mga2p expression. with the anti-HA antibody and not with the isotype con-
trol (I) antibody, indicating that Mga2p90 and Mga2p120Also, it contains a carboxy-terminal HA epitope tag,
and this allows for preferential immunopurification of interact. Because the IPT domain is required for
Spt23p90 and Mga2p90 production ([3] and data notMga2p120 with the anti-HA antibody. As depicted in
Figure 2C, we measured less ubiquitinated MYCMga2p shown), we were unable to test by coimmunoprecipita-
tion if the Mga2p90-Mga2p120 interaction depends onin npl4-1 mutant cells expressing HARsp5pC. Fig-
ure 2D shows the presence of polyubiquitinated the IPT domain. Therefore, we tested for dimeric interac-
Activation of Mga2p by Rsp5p
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Figure 4. Rsp5p Binds a Mga2p90-Mga2p120 Complex
(A) MYCMGA2 cells were transformed with plasmid encoding galactose-inducible HARsp5p or with an empty vector control (V). Single colonies
were grown in glucose-containing media and then incubated in galactose media. Cells were pelleted and lysed, and immunoprecipitation and
Western blotting were carried out with the indicated antibodies.
(B) Abbreviations for depicted structural domains are described in the Supplemental Data. His6X-tagged recombinant Rsp5p polypeptide was
purified from bacteria via Ni2 agarose beads and incubated with labeled Mga2p120 or Mga2p carboxy-terminal mutants. Protein complexes
were processed as described in Figure 3B. The left panel depicts recombinant Rsp5p (detected by Coomassie staining) and in vitro-translated
Mga2p (detected by fluorography) placed in the binding assay.
(C) Binding assays with His6X-tagged Rsp5p WW domains and the labeled M3 Mga2p mutant were performed as described above, except
that binding reactions included either no Mga2p (-) or, alternatively, unlabeled in vitro-translated Mga2p120 or Mga2p120IPT containing
reticulocyte lysate. Bound Mga2p was measured by fluorography for labeled M3 or by Western blotting for unlabeled Mga2p120.
(D) Proposed model of Mga2p activation by Rsp5p. Sites of ubiquitin conjugation remain to be identified.
tions by using an in vitro pull-down assay with recombi- in extracts containing HARsp5p (Figure 4A). These pro-
teins were not present in control immunoprecipitationsnant His6X-Mga2p and in vitro-translated Mga2p. As
shown in Figure 3B, we found that Mga2p forms dimers or in cells lacking HARsp5p. To further investigate the
Rsp5p-Mga2p interaction, we generated a series of car-and that dimerization is dependent on the IPT domain.
To determine if Rsp5p interacts with Mga2p120- boxy-terminal Mga2p deletion mutants. These mutants,
as well as full-length Mga2p, were tested for Rsp5pMga2p90 complexes, extracts were prepared from cells
expressing MYCMga2p and HARsp5p or MYCMga2p alone, binding. An in vitro association assay was chosen to
avoid interpretation difficulties arising from likely differ-and immunoprecipitations were performed. As shown
in Figure 4A, MYCMag2p90 and MYCMga2p120 were coim- ential expression, localization, and activity of the mu-
tants in cells. The source of Rsp5p for these bindingmunoprecipitated with an antibody recognizing HARsp5p
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studies was recombinant His6X-tagged Rsp5p con- needs to be defined. We have found by using an in vitro
binding assay that the Rsp5p binding site on Mga2p istaining the substrate binding domains of the ligase (i.e.,
WW domains 1 through 3), whereas Mga2p proteins located within a region (between or perhaps surrounding
amino acids 910–1029) that is probably present only withwere generated in rabbit reticulocytes. Rsp5p was found
to bind robustly with full-length Mga2p and the M1 mu- the membrane bound anchor. This interaction specificity
could be important for dictating Rsp5p-dependent poly-tant (Figure 4B). Only background binding was detected
between Rsp5p and the M2 and M3 mutants. These ubiquitination of the membrane bound anchor while
sparing the transcriptionally competent form from thisresults indicate that the Rsp5p binding domain is lo-
cated within the carboxyl terminus of Mga2p120, and potentially deleterious modification process. Interest-
ingly, there is only one known putative WW binding siteMga2p90 interacts with Rsp5p via Mga2p120. We next
performed a Rsp5p binding assay with the radioactively (i.e., L967PKY971) within this region, and such a motif has
been shown previously to interact with Group I WWlabeled M3 mutant in the presence of unlabeled
Mga2p120 or Mga2p120IPT. As shown in Figure 4C, domains 2 and 3 of Rsp5p [10]. It should also be noted
that besides phosphorylation-dependent (Sp/Tp)P sites,we detected a greater amount of the M3 mutant in pull-
downs containing His6X-tagged Rsp5p and Mga2p120 the LPKY sequence is the only known WW binding site
within the protein. Curiously, this site and surroundingin the binding reaction than we did in those containing
His6X-tagged Rsp5p and Mga2p120IPT. Similar amounts sequences are remarkably conserved in Spt23p. Thus,
it is possible that there is another WW domain containingof Mga2p120 and Mga2p120IPT were present in these
Rsp5p pull-downs, whereas only background binding ligase responsible for Spt23p120 polyubiquitination and
release of tethered Spt23p90 or that Rsp5p plays dualwas detected in reactions containing only His6X-tagged
Rsp5p and the M3 mutant. We conclude from these ex- roles in Spt23p activation, perhaps by binding to distinct
sites. Alternatively, Rsp5p may activate Mga2p andperiments that Rsp5p interacts with dimeric Mga2p120-
Mga2p90 via a domain that is contained only within Spt23p function by a similar mechanism. Suppression of
Spt23p processing in cells expressing ligase-defectiveMga2p120.
Rsp5p mutants could be due to nonspecific binding
effects of the mutants on the processing reaction or on
Discussion loss of other Rsp5p-regulated processes. In rsp5 cells,
partial degradation may be affected by the presence of
Results presented here suggest that Rsp5p is dispens- high amounts of unsaturated fatty acids or may be due
able for Mga2p120 processing. Although mechanisms to the loss of other Rsp5p-dependent activities. Future
involved in Mga2p processing remain uncharacterized, studies are needed to test the model proposed here and
our unpublished studies have revealed that Mga2p90 to determine if it applies to other eukaryotic transcription
generation does not require ER retention or a region factors that are embedded/tethered at the ER or other
required for Rsp5p binding in vitro. Also, we have found cellular membranes.
that processing does require the IPT dimerization do-
main and is suppressed in proteasome-deficient strains. Supplemental Data
Thus, it is possible that Mga2p90 is generated by a Supplemental Data including Experimental Procedures and yeast
strains are available with this article online at http://www.current-mechanism similar to that of its distant cousin, the p50
biology.com/cgi/content/full/13/14/1227/DC1/.subunits of the NF-kB complex [9]. Whether this requires
ubiquitination is unclear, although it is curious to note
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